Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study

Abstract Background and Objectives Direct-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of cancer after HCV eradication remain. Our study aimed at quantifying the incidence of cancer in patients treated with anti-HCV therapies in Cat...

詳細記述

書誌詳細

出版年:	Drugs - Real World Outcomes
主要な著者:	José Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros, María Reig, Ferran Torres, Caridad Pontes
フォーマット:	論文
言語:	英語
出版事項:	Adis, Springer Healthcare 2024-06-01
オンライン･アクセス:	https://doi.org/10.1007/s40801-024-00437-y